ReWalk Robotics Ltd. Q3 2025 Earnings Recap

LFWD Q3 2025 November 14, 2025

Get alerts when LFWD reports next quarter

Lifeward Ltd. achieved a modest revenue increase in Q3 2025, with significant operational improvements reflected in reduced cash burn and operating losses, indicating a focused transformation underway.

Earnings Per Share Miss

$-0.20 vs $-0.09 est.

-122.2% surprise

Revenue Miss

6195000 vs 7867500 est.

-21.3% surprise

Market Reaction

1-Day -0.56%

5-Day -12.4%

30-Day +6.96%

See LFWD alongside your other holdings

Add to your portfolio — free

Key Takeaways

Quarterly revenue rose 8% sequentially to $6.2 million, driven by record ReWalk placements for Medicare beneficiaries.
Non-GAAP operating loss decreased by 27% year-over-year, signaling improved operational efficiency.
Established first Medicare Advantage commercial revenue and received CE Mark approval, expanding European market access.
Implemented a $3 million loan to strengthen liquidity and support the ongoing transformation plan.
Closed with over 200 systems in backlog and a healthy pipeline of qualified leads in the U.S. and Germany.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit LFWD on AllInvestView.